These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36286042)

  • 1. Induction of Breast Cancer Cell Apoptosis by TRAIL and Smac Mimetics: Involvement of RIP1 and cFLIP.
    Holmgren C; Sunström Thörnberg E; Granqvist V; Larsson C
    Curr Issues Mol Biol; 2022 Oct; 44(10):4803-4821. PubMed ID: 36286042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combination of TRAIL and the Smac mimetic LCL-161 induces an irreversible phenotypic change of MCF-7 breast cancer cells.
    Granqvist V; Holmgren C; Larsson C
    Exp Mol Pathol; 2022 Apr; 125():104739. PubMed ID: 35007560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of interferon-β and interferon signaling by TRAIL and Smac mimetics via caspase-8 in breast cancer cells.
    Granqvist V; Holmgren C; Larsson C
    PLoS One; 2021; 16(3):e0248175. PubMed ID: 33770100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PKC activation sensitizes basal-like breast cancer cell lines to Smac mimetics.
    Cornmark L; Holmgren C; Masoumi K; Larsson C
    Cell Death Discov; 2016; 2():16002. PubMed ID: 27551497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperative TRAIL production mediates IFNα/Smac mimetic-induced cell death in TNFα-resistant solid cancer cells.
    Roesler S; Eckhardt I; Wolf S; Fulda S
    Oncotarget; 2016 Jan; 7(4):3709-25. PubMed ID: 26788912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RIP1 Cleavage in the Kinase Domain Regulates TRAIL-Induced NF-κB Activation and Lymphoma Survival.
    Zhang L; Blackwell K; Workman LM; Chen S; Pope MR; Janz S; Habelhah H
    Mol Cell Biol; 2015 Oct; 35(19):3324-38. PubMed ID: 26195820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL- and etoposide-induced apoptosis in breast cancer cells.
    Bockbrader KM; Tan M; Sun Y
    Oncogene; 2005 Nov; 24(49):7381-8. PubMed ID: 16044155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular FLICE-inhibitory protein (cFLIP) isoforms block CD95- and TRAIL death receptor-induced gene induction irrespective of processing of caspase-8 or cFLIP in the death-inducing signaling complex.
    Kavuri SM; Geserick P; Berg D; Dimitrova DP; Feoktistova M; Siegmund D; Gollnick H; Neumann M; Wajant H; Leverkus M
    J Biol Chem; 2011 May; 286(19):16631-46. PubMed ID: 21454681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The sesquiterpene lactone eupatolide sensitizes breast cancer cells to TRAIL through down-regulation of c-FLIP expression.
    Lee J; Hwangbo C; Lee JJ; Seo J; Lee JH
    Oncol Rep; 2010 Jan; 23(1):229-37. PubMed ID: 19956887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential response of head and neck cancer cell lines to TRAIL or Smac mimetics is associated with the cellular levels and activity of caspase-8 and caspase-10.
    Raulf N; El-Attar R; Kulms D; Lecis D; Delia D; Walczak H; Papenfuss K; Odell E; Tavassoli M
    Br J Cancer; 2014 Nov; 111(10):1955-64. PubMed ID: 25314064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential and molecular mechanism of a novel, potent, nonpeptide, Smac mimetic SM-164 in combination with TRAIL for cancer treatment.
    Lu J; McEachern D; Sun H; Bai L; Peng Y; Qiu S; Miller R; Liao J; Yi H; Liu M; Bellail A; Hao C; Sun SY; Ting AT; Wang S
    Mol Cancer Ther; 2011 May; 10(5):902-14. PubMed ID: 21372226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism.
    Allensworth JL; Sauer SJ; Lyerly HK; Morse MA; Devi GR
    Breast Cancer Res Treat; 2013 Jan; 137(2):359-71. PubMed ID: 23225169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of FLICE-like inhibitory protein expression with small interfering RNA oligonucleotides is sufficient to sensitize tumor cells for TRAIL-induced apoptosis.
    Siegmund D; Hadwiger P; Pfizenmaier K; Vornlocher HP; Wajant H
    Mol Med; 2002 Nov; 8(11):725-32. PubMed ID: 12520089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-overexpression of TRAIL and Smac sensitizes MDA-MB-231 cells to radiation through apoptosis depending on mitochondrial pathway.
    Xu W; Fang F; Wang Y; Qin L; Han Y; Huang Y; Li B; Liu Y; Wang Z
    Radiat Environ Biophys; 2022 Mar; 61(1):37-48. PubMed ID: 35006369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel SMAC-mimetics synergistically stimulate melanoma cell death in combination with TRAIL and Bortezomib.
    Lecis D; Drago C; Manzoni L; Seneci P; Scolastico C; Mastrangelo E; Bolognesi M; Anichini A; Kashkar H; Walczak H; Delia D
    Br J Cancer; 2010 Jun; 102(12):1707-16. PubMed ID: 20461078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smac mimetics and type II interferon synergistically induce necroptosis in various cancer cell lines.
    Cekay MJ; Roesler S; Frank T; Knuth AK; Eckhardt I; Fulda S
    Cancer Lett; 2017 Dec; 410():228-237. PubMed ID: 28923396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NCTD promotes Birinapant-mediated anticancer activity in breast cancer cells by downregulation of c-FLIP.
    Zhao L; Yang G; Bai H; Zhang M; Mou D
    Oncotarget; 2017 Apr; 8(16):26886-26895. PubMed ID: 28460471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ITCH-dependent proteasomal degradation of c-FLIP induced by the anti-HER3 antibody 9F7-F11 promotes DR5/caspase 8-mediated apoptosis of tumor cells.
    Le Clorennec C; Lazrek Y; Dubreuil O; Sampaio C; Larbouret C; Lanotte R; Poul MA; Barret JM; Prost JF; Pèlegrin A; Chardès T
    Cell Commun Signal; 2019 Aug; 17(1):106. PubMed ID: 31443721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smac mimetic reverses resistance to TRAIL and chemotherapy in human urothelial cancer cells.
    Metwalli AR; Khanbolooki S; Jinesh G; Sundi D; Shah JB; Shrader M; Choi W; Lashinger LM; Chunduru S; McConkey DJ; McKinlay M; Kamat AM
    Cancer Biol Ther; 2010 Nov; 10(9):885-92. PubMed ID: 20814238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
    Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
    Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.